Appalling focus in this article on the "threats" to US corporate profiteering from cancer. How about the benefits to, you know, human beings with cancer? A reminder that patients are commodities in US.
"China’s Rise in Drug Development Looms Over U.S." www.nytimes.com/2026/05/30/b...
